PDF herunterladen
Semin intervent Radiol 2023; 40(02): 151-155
DOI: 10.1055/s-0043-1768955
Review Article

Aortoiliac: Covered, Uncovered, CERAB as It Relates to Peripheral Arterial Disease

Sayeh Bozorghadad
1   Department of Radiology, Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
,
Matthew J. Scheidt
1   Department of Radiology, Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
,
Parag J. Patel
1   Department of Radiology, Vascular and Interventional Radiology, Medical College of Wisconsin, Milwaukee, Wisconsin
› Institutsangaben
› Weitere Informationen
Auch verfügbar auf
    Lizenzen und Reprints

Abstract

Peripheral arterial disease (PAD) affects over 200 million worldwide and is the leading cause of major limb amputation, with individuals suffering from PAD being at three times greater risk of dying compared with matched controls. TASC-II guidelines provide a consensus on the management of PAD based on the collaboration between international vascular specialties. These guidelines previously outlined open surgery as the gold standard for treatment of aortoiliac disease and PAD as it has demonstrated consistent long-term results. However, this approach is also associated with high perioperative mortality, especially when compared with endovascular techniques. With recent developments in endovascular technology, user technique, and experience, this approach has become more widely used as primary intervention for aortoiliac disease. One of these novel techniques includes covered endovascular reconstruction of the aortic bifurcation, which has demonstrated excellent technical success and improved primary and secondary patency rates with follow-up. The aim of this review is to compare the efficacy of these approaches to the treatment of aortoiliac disease and demonstrate the benefits of the shift toward an endovascular-first approach to treatment of this disease, regardless of lesion complexity or severity.

Keywords

aortoiliac occlusive disease - endovascular - CERAB - iliac artery - aorta - interventional radiology


Publikationsverlauf

Artikel online veröffentlicht:
16. Juni 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Saratzis A, Salem M, Sabbagh C. et al. Treatment of aortoiliac occlusive disease with the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique: results of a UK multicenter study. J Endovasc Ther 2021; 28 (05) 737-745
    CrossrefPubMedGoogle Scholar
  • 2 Salem M, Hosny MS, Francia F. et al. Management of extensive aorto-iliac disease: a systematic review and meta-analysis of 9319 patients. Cardiovasc Intervent Radiol 2021; 44 (10) 1518-1535
    CrossrefPubMedGoogle Scholar
  • 3 Indes JE, Pfaff MJ, Farrokhyar F. et al. Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis. J Endovasc Ther 2013; 20 (04) 443-455
    CrossrefPubMedGoogle Scholar
  • 4 Jaff MR, White CJ, Hiatt WR. et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): the TASC Steering Committee. Ann Vasc Dis 2015; 8 (04) 343-357
    CrossrefPubMedGoogle Scholar
  • 5 Norgren L, Hiatt WR, Dormandy JA. et al; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007; 33 (Suppl. 01) S1-S75
    CrossrefPubMedGoogle Scholar
  • 6 Jongkind V, Akkersdijk GJM, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg 2010; 52 (05) 1376-1383
    CrossrefPubMedGoogle Scholar
  • 7 Mayor J, Branco BC, Chung J. et al. Outcome comparison between open and endovascular management of TASC II D aortoiliac occlusive disease. Ann Vasc Surg 2019; 61 (61) 65-71.e3
    CrossrefPubMedGoogle Scholar
  • 8 Ye W, Liu CW, Ricco JB, Mani K, Zeng R, Jiang J. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions. J Vasc Surg 2011; 53 (06) 1728-1737
    CrossrefPubMedGoogle Scholar
  • 9 Antonello M, Squizzato F, Bassini S, Porcellato L, Grego F, Piazza M. Open repair versus endovascular treatment of complex aortoiliac lesions in low risk patients. J Vasc Surg 2019; 70 (04) 1155-1165.e1
    CrossrefPubMedGoogle Scholar
  • 10 Rocha-Neves J, Ferreira A, Sousa J. et al. Endovascular approach versus aortobifemoral bypass grafting: outcomes in extensive aortoiliac occlusive disease. Vasc Endovascular Surg 2020; 54 (02) 102-110
    CrossrefPubMedGoogle Scholar
  • 11 Dorigo W, Piffaretti G, Benedetto F. et al. A comparison between aortobifemoral bypass and aortoiliac kissing stents in patients with complex aortoiliac obstructive disease. J Vasc Surg 2017; 65 (01) 99-107
    CrossrefPubMedGoogle Scholar
  • 12 Piffaretti G, Fargion AT, Dorigo W. et al; ILIACS Registry Group. Outcomes from the Multicenter Italian Registry on primary endovascular treatment of aortoiliac occlusive disease. J Endovasc Ther 2019; 26 (05) 623-632
    CrossrefPubMedGoogle Scholar
  • 13 Grimme FAB, Goverde PCJM, Verbruggen PJEM, Zeebregts CJ, Reijnen MM. Editor's choice – first results of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 2015; 50 (05) 638-647
    CrossrefPubMedGoogle Scholar
  • 14 Goverde PCJM, Grimme FAB, Verbruggen PJEM, Reijnen MM. Covered endovascular reconstruction of aortic bifurcation (CERAB) technique: a new approach in treating extensive aortoiliac occlusive disease. J Cardiovasc Surg (Torino) 2013; 54 (03) 383-387
    PubMedGoogle Scholar
  • 15 Bredahl K, Jensen LP, Schroeder TV, Sillesen H, Nielsen H, Eiberg JP. Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease. J Vasc Surg 2015; 62 (01) 75-82
    CrossrefPubMedGoogle Scholar
  • 16 Maitrias P, Deltombe G, Molin V, Reix T. Iliofemoral endarterectomy associated with systematic iliac stent grafting for the treatment of severe iliofemoral occlusive disease. J Vasc Surg 2017; 65 (02) 406-413
    CrossrefPubMedGoogle Scholar
  • 17 Foley TR, Singh GD, Kokkinidis DG. et al. High-intensity statin therapy is associated with improved survival in patients with peripheral artery disease. J Am Heart Assoc 2017; 6 (07) e005699
    CrossrefPubMedGoogle Scholar
  • 18 Pandey A, Banerjee S, Ngo C. et al. Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials. JACC Cardiovasc Interv 2017; 10 (07) 712-724
    CrossrefPubMedGoogle Scholar
  • 19 Jansen SCP, van Nistelrooij LPJ, Scheltinga MRM, Rouwet EV, Teijink JAW, Vahl AC. Successful implementation of the exercise first approach for intermittent claudication in the Netherlands is associated with few lower limb revascularisations. Eur J Vasc Endovasc Surg 2020; 60 (06) 881-887
    CrossrefPubMedGoogle Scholar
  • 20 Rossi M, Iezzi R. Cardiovascular and Interventional Radiological Society of Europe guidelines on endovascular treatment in aortoiliac arterial disease. Cardiovasc Intervent Radiol 2014; 37 (01) 13-25
    CrossrefPubMedGoogle Scholar